Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. Operating Income 2016–2025
Collegium Pharmaceutical Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Collegium Pharmaceutical Inc. operating income for the quarter ending March 31, 2026 was 30.9 M, a 42.46% increase year-over-year.
- Collegium Pharmaceutical Inc. operating income for the twelve months ending March 31, 2026 was 149.8 M, a 15.28% decrease year-over-year.
- Collegium Pharmaceutical Inc. annual operating income for 2025 was 179.6 M, a 5.73% increase from 2024.
- Collegium Pharmaceutical Inc. annual operating income for 2024 was 169.9 M, a 1.76% increase from 2023.
- Collegium Pharmaceutical Inc. annual operating income for 2023 was 167.0 M, a 401.10% increase from 2022.
- Collegium Pharmaceutical Inc. annual operating income for 2022 was 33.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Collegium Pharmaceutical Inc. Operating Income — FAQ
Collegium Pharmaceutical Inc. (COLL) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Collegium Pharmaceutical Inc.'s operating income?
Collegium Pharmaceutical Inc. (COLL) reported operating income of $180M for fiscal 2025.
Where can I see COLL's operating income history?
The chart and table above show Collegium Pharmaceutical Inc.'s operating income by year and by quarter, including the growth rate.